Company Encyclopedia
View More
name
Bosera Research Selected Flexible Configuration Hybrid Fund(LOF)-A
160527.SZ
News
View More

Polestar secures $600 million lifeline from majority owner Geely

Polestar has secured a $600 million loan from Geely Sweden Holdings AB to stabilize its balance sheet amid cash burn and industry pressures. The loan is structured as subordinated, not affecting existing $5.5 billion debt. This follows previous loans totaling $1.4 billion. Despite financial challenges, including a Q3 net loss of $365 million, Polestar continues expanding its lineup, launching Polestar 4 deliveries in Canada and the U.S.

DriveTeslaCanada·
US
PSNY
-2.75%
US
GELYY
0.00%
HK
00175
-1.49%
DriveTeslaCanada·
US
PSNY
-2.75%
US
GELYY
0.00%
HK
00175
-1.49%

Global lithium prices spike but remain below 2024 average, says Chile's Cochilco

Global lithium carbonate prices have risen recently due to supply uncertainty and increased demand, reaching $10,500/ton, a 13% increase since October. Despite this rise, prices remain below last year's average. Higher consumption for lithium battery energy storage systems is driving prices up, despite a projected market surplus. Uncertainty over CATL's Jianxiawo mine reopening in China affects supply. Prices may recover moderately in 2026, but the mine's restart could lower prices short-term. Chile is the second largest lithium producer globally.

Reuters·
HK
03750
+0.99%
SZ
300750
+1.32%
Reuters·
HK
03750
+0.99%
SZ
300750
+1.32%

Top 10 HK Stock Gainers (12.17)

YOFC(06869) rose 21.21%, with a trading turnover 3.1 Billion HKD, and a year-to-date rose 290.1%. TRANSTHERA-B(02617) rose 17.41%, with a trading turnover 389.9 Million HKD, and a year-to-date rose 1202.7%. DRINDA(02865) rose 11.91%, with a trading turnover 100.8 Million HKD, and a year-to-date fell 19.4%.

Top Gainers & Losers·
HK
06869
+21.21%
HK
02617
+17.41%
HK
02865
+11.91%
Top Gainers & Losers·
HK
06869
+21.21%
HK
02617
+17.41%
HK
02865
+11.91%

Top 5 HK Stock Gainers/Losers (>100B) (12.17)

CHINA SOUTH AIR(01055) rose 5.89%, with a trading turnover 303.5 Million HKD, and a year-to-date rose 36.5%. GANFENGLITHIUM(01772) rose 5.75%, with a trading turnover 1.1 Billion HKD, and a year-to-date rose 160.3%. TECHTRONIC IND(00669) fell 2.02%, with a trading turnover 516.9 Million HKD, and a year-to-date fell 10.3%. HORIZONROBOT-W(09660) fell 1.84%, with a trading turnover 1.1 Billion HKD, and a year-to-date rose 137.2%.

Top Gainers & Losers·
HK
01055
+5.89%
HK
01772
+5.75%
HK
02628
+4.31%
Top Gainers & Losers·
HK
01055
+5.89%
HK
01772
+5.75%
HK
02628
+4.31%

The Bull Case For Akeso (SEHK:9926) Could Change Following FDA Clearance Of Global Gastric Cancer Trial

Akeso has received FDA approval for a global Phase III trial of cadonilimab in advanced HER2-negative gastric cancer, marking a significant milestone in its oncology efforts. This approval positions cadonilimab against current chemotherapy standards, potentially reshaping Akeso's investment narrative. Despite ongoing losses, Akeso projects CN¥8.0 billion revenue and CN¥2.0 billion earnings by 2028, with a fair value estimate of HK$172.00, a 47% upside. The FDA clearance adds execution risk but could validate Akeso's reliance on cadonilimab and ivonescimab as core value drivers.

Simplywall·
HK
09926
+0.17%
Simplywall·
HK
09926
+0.17%
© 2025 Longbridge｜Disclaimer